A-H Premium Weekly (Oct 28th): Pharmaron, Datang Intl, Shanghai Junshi, Tianqi Lithium
We analyzed A-H premium changes in the past week and highlight A-H premium changes for Pharmaron, Datang Intl, Shanghai Junshi, Tianqi Lithium.
206 Views
Giant Biogene IPO - Reasonable Valuation but in Unreasonable Markets
Giant Biogene is now looking to raise around US$80m in its Hong Kong IPO, down from its earlier target of US$500m raising.
228 Views
Hong Kong Connect Flows (Oct 21st): $3.2bn Inflows
We analyzed the Hong Kong Connect Scheme for last week and highlight $3.2bn inflows last week and flows for Tencent, Meituan, Wuxi Biologics.
248 Views
Giant Biogene Pre-IPO - Thoughts on Valuation
Giant Biogene Holding (GBH HK) aims to raise around US$500m in its Hong Kong IPO. In this note, we talk about valuations.
224 Views
Giant Biogene Pre-IPO - Peer Comparison - Might Need to Spend a Lot More Online
Giant Biogene Holding aims to raise around US$500m in its Hong Kong IPO. In this note, we will undertake a peer comparison.
286 Views